Rivaroxaban for Patients with Intermittent Claudication

In patients with peripheral artery disease and intermittent claudication, 2.5 mg of rivaroxaban twice daily plus 100 mg of aspirin daily improved the total walking distance by a 6-minute walking test compared with 100 mg of aspirin daily alone. (Funded by Bayer S.A.; Clinicaltrials.gov number, NCT04853719.).

Authors

Institutions

Publication Details

Journal
NEJM Evidence
Published
2024-08-26
DOI
https://doi.org/10.1056/evidoa2400021
Citations
7
Primary Topic
Peripheral Artery Disease Management
Type
article
Field-Weighted Citation Impact
4.01
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Rivaroxaban for Patients with Intermittent Claudication

Jawed Fareed, Heron Rhydan Saad Rached, Chang Chiann, Alexia Paganotti et al.
7 citations
NEJM Evidence
Peripheral Artery Disease Management
4.01
article

Rivaroxaban for Patients with Intermittent Claudication

Jawed Fareed, Heron Rhydan Saad Rached, Chang Chiann, Alexia Paganotti, Felipe Menegueti Pereira, Rogério Krakauer, Roberto Augusto Caffaro, Valéria Cristina Resende Aguiar, Nelson Wolosker, Karen Falcão Britto, Camilla Moreira Ribeiro, Sonia Savitri Anand, Renato D. Lópes, Eduardo Ramacciotti, Leandro Barile Agati, Giuliano Giová Volpiani, John W. Eikelboom
article en
7 citations

Abstract

In patients with peripheral artery disease and intermittent claudication, 2.5 mg of rivaroxaban twice daily plus 100 mg of aspirin daily improved the total walking distance by a 6-minute walking test compared with 100 mg of aspirin daily alone. (Funded by Bayer S.A.; Clinicaltrials.gov number, NCT04853719.).

NEJM EvidenceVol. 3(9)
Loyola University Medical Center (US), Duke University (US), Universidade de São Paulo (BR), Hospital Israelita Albert Einstein (BR), Population Health Research Institute (CA), Irmandade da Santa Casa de Misericórdia de São Paulo (BR), Clinical Research Institute (US), Hospital Leforte (BR), Czech Academy of Sciences, Institute of Mathematics (CZ), McMaster University (CA)
Openalex Percentile: Top 6%
Peripheral Artery Disease Management
4.01
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.